Ethic Inc. Coherus Bio Sciences, Inc. Transaction History
Ethic Inc.
- $4.83 Billion
- Q4 2024
A detailed history of Ethic Inc. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Ethic Inc. holds 11,397 shares of CHRS stock, worth $13,448. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,397Holding current value
$13,448% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CHRS
# of Institutions
133Shares Held
70MCall Options Held
1.16MPut Options Held
39.5K-
Black Rock Inc. New York, NY11.8MShares$13.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$13.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.28MShares$6.23 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$6.21 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA3.65MShares$4.31 Million0.38% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $91.7M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...